Market Research Report
Germ Cell Tumors Global Clinical Trials Review, H1, 2012
|Published by||GlobalData||Product code||242603|
|Published||Content info||77 Pages
|Germ Cell Tumors Global Clinical Trials Review, H1, 2012|
|Published: May 21, 2012||Content info: 77 Pages||
This publication has been discontinued on February 2, 2017.
GlobalData's clinical trial report, "Germ Cell Tumors Global Clinical Trials Review, H1, 2012" provides data on the Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germ Cell Tumors. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Germ Cell Tumors Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Germ Cell Tumors , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.